The Role of Endothelial Glycocalyx in Kidney Transplantation
NCT ID: NCT05651906
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2022-12-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim is to summarize the current knowledge and to point out the importance of EG in kidney transplantation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endothelial Glycocalyx Damage in Brain Death Organ Donors
NCT05609123
Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study
NCT02555566
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
NCT05650619
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
NCT01515605
Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function
NCT02568696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Donors
No interventions assigned to this group
Recipients
Kidney Transplantation
Kidney transplantation as the best option for patients with end-stage kidney disease.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kidney Transplantation
Kidney transplantation as the best option for patients with end-stage kidney disease.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pavel Navrátil, MUDr., FEBU
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Hradec Kralove
Hradec Králové, Czech Republic, Czechia
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GCX-KTX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.